Evidence map›Paper›PMID 36498626›Full record

ArticleJournal of clinical medicine2022

Assessment of Pulmonary Function Tests in COVID-19 Convalescents Six Months after Infection.

Katarzyna Guziejko, Anna Moniuszko-Malinowska, Piotr Czupryna, Marlena Dubatówka, Magda Łapińska, Andrzej Raczkowski, Paweł Sowa, Łukasz Kiszkiel, Łukasz Minarowski, Marcin Moniuszko and 2 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Katarzyna Guziejko2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland.ORCID 0000-0002-2646-364X
Anna Moniuszko-MalinowskaDepartment of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland.ORCID 0000-0002-3994-8785
Piotr CzuprynaDepartment of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland.ORCID 0000-0002-0072-2180
Marlena DubatówkaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, ul. J. Kilinskiego 1, 15-259 Bialystok, Poland.ORCID 0000-0001-5977-0745
Magda ŁapińskaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, ul. J. Kilinskiego 1, 15-259 Bialystok, Poland.
Andrzej RaczkowskiDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, ul. J. Kilinskiego 1, 15-259 Bialystok, Poland.
Paweł SowaDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, ul. J. Kilinskiego 1, 15-259 Bialystok, Poland.ORCID 0000-0002-8357-5816
Łukasz KiszkielSociety and Cognition Unit, University of Bialystok, 15-403 Bialystok, Poland.ORCID 0000-0002-0712-3260
Łukasz Minarowski2nd Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland.
Marcin MoniuszkoDepartment of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Waszyngtona 13, 15-269 Bialystok, Poland.
Monika GrothDepartment of Infectious Diseases and Neuroinfections, Medical University of Bialystok, Zurawia 14, 15-540 Bialystok, Poland.
Karol A KaminskiDepartment of Population Medicine and Lifestyle Diseases Prevention, Medical University of Bialystok, ul. J. Kilinskiego 1, 15-259 Bialystok, Poland.ORCID 0000-0002-9465-2581

Funding

National Science Centre, Poland 2020/37/B/NZ7/03380
6 · The paper itself

Abstract

Background: The aim of the study was to investigate the impact of COVID-19 on the pulmonary function tests (PFT) in COVID-19 convalescents six months after recovery. Additionally, the research question was whether PFT should be performed routinely in post-COVID-19 patients. Methods: A total of 39 patients with a history of COVID-19 6 months prior to the study were included in the study (Group I). Individuals were hospitalized or treated in the outpatients department. The control group (Group II) consisted of 39 healthy patients without a COVID-19 history. Each subject completed a questionnaire interview and underwent laboratory and pulmonary function examinations. Results: Six months after COVID-19 recovery, patients mainly complained about cough (46%, n = 18), shortness of breath (23%, n = 9), weakness (13%, n = 5), and memory/concentration disorders (8%, n = 3). In the group of patients complaining of persistent cough present 6 months after COVID-19, the following PFT parameters were decreased: FEV1, FVC, FRC, TLC, and DLCO (p < 0.05) in comparison with patients without this symptom. Conclusions: Persistent shortness of breath is not necessarily associated with pulmonary function impairment in patients 6 months after SARS-CoV-2 infection, and hence it requires appropriate differential diagnosis. Patients with a cough persisting 6 months after the acute phase of COVID-19 may benefit from PFT.

Indexed as

coughCOVID-19pulmonary function testrecoveryshortness of breath

Identifiers

PMID36498626
PMCPMC9737969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.